Patent details

Basic Information

Publication number:

LUC00318

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP147610620

Legal Status:

Inactive

Application number:

LUC00318

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/23/1736

Marketing Authorization Type:

Marketing Authorization Date:

30/05/2023

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

23/10/2023

First Marketing Authorization date:

30/05/2023

Grant date:

02/02/2026

Activation date:

Publication date:

24/10/2023

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

30/05/2038

SPC Extension Expiration:

30/05/2038

Rejection date:

Withdrawal date:

Owner

From:

23/10/2023

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/10/2023

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2023/12

Publication date:

06/11/2023

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2026/04

Publication date:

03/03/2026

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

31/03/2034

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
23/10/2023	Summary of the product caracteristics	88
23/10/2023	MA publication	10
24/10/2023	Outgoing Correspondence	1
23/10/2023	Application Form	3
23/10/2023	Marketing authorization	3
24/10/2023	Publication	1
02/02/2026	Publication	1
02/02/2026	Certificate	1
02/02/2026	Outgoing Correspondence	1